CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Thursday
Analysts revised price targets for Ultragenyx, UiPath, Netskope, Snowflake, Magnite, Broadcom, CrowdStrike and Moderna; ratings largely maintained.
Stocks · News reference
RBC Capital analyst Matthew Swanson maintains Magnite (NASDAQ:MGNI) with a Outperform and raises the price target from $20 to $27.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Analysts revised price targets for Ultragenyx, UiPath, Netskope, Snowflake, Magnite, Broadcom, CrowdStrike and Moderna; ratings largely maintained.
Magnite announced major milestones in its live streaming advertising business, launching Live Scheduler technology that has enabled 37 media owners to schedule and monetize over 4,000 live events. The platform saw a 56% year-over-year increase in global live sports ad spend from January to July, with over 5,800 new advertisers. Key features include precision activation, infrastructure for viewership spikes, and access via programmatic or agentic workflows.
Needham analyst Laura Martin maintains Magnite (NASDAQ:MGNI) with a Buy and raises the price target from $25 to $30.
Magnite director Paul Caine sold 7,500 shares for $187,500 on August 14, 2026, under a pre-established Rule 10b5-1 trading plan. Despite the sale reducing his direct stake by 5%, Caine maintains approximately 149,901 shares worth $3.7 million, indicating continued confidence in the company. Analysts remain bullish on Magnite with 83% rating it a buy and a median price target of $27.